Basaglar (insulin glargine) is the newest brand of long-acting insulin to hit the market. It shares its active ingredient (insulin glargine) with Lantus, but is not a generic equivalent and the two can’t be substituted for each other.
Long-acting insulin like Basaglar (also sometimes referred to as basal insulin) are used to keep blood glucose levels stable throughout the day.
Is there anything unique about Basaglar?
No. In the US, Basaglar was approved as a new drug, which means it has to prescribed by your doctor—or approved as a new prescription if you switch from Lantus. Although both Basaglar and Lantus are both insulin glargine they cannot be automatically substituted for one another without your doctor’s approval.
How is Basaglar used?
Dosing with Basaglar is individualized and will be determined by your doctor—not everyone will use the same amount. Basaglar is injected once-daily at any time of the day (but should be used at the same time every day).
What are the side effects of Basaglar?
The most common side effects associated with Basaglar are low blood sugar, allergic reactions, injection site reactions, itching, rash, and retaining water.
Want more information?
Check out the the press announcement from the manufacturer Eli Lilly here and see the announcement from the FDA here.